Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy? - Université de Rennes Accéder directement au contenu
Article Dans Une Revue European Journal of Cancer Année : 2016

Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?

Résumé

Downregulation/loss of the antigen presentation is a major immune escape mechanism in cancer. It allows tumour cells to become ‘invisible’ and avoid immune attack by antitumour T cells. In tumour harbouring properties of professional antigen presenting cells (i.e. tumour B cells in lymphoma), downregulation/loss of the antigen presentation may also prevent direct priming of naïve T cells by tumour cells. Here, we review treatments that may induce/restore antigen presentation by the tumour cells. These treatments may increase the generation of antitumour T cells and/or their capacity to recognise and eliminate tumour cells. By forcing tumour cells to present their antigens, these treatments may sensitise patients to T cell–based immunotherapies, including checkpoint inhibitors. © 2016 Elsevier Ltd

Domaines

Cancer
Fichier non déposé

Dates et versions

hal-01416159 , version 1 (14-12-2016)

Identifiants

Citer

Marie De Charette, Aurélien Marabelle, Roch Houot. Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?. European Journal of Cancer, 2016, 68, pp.134--147. ⟨10.1016/j.ejca.2016.09.010⟩. ⟨hal-01416159⟩
183 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More